Navigation Links
PETCO Adds Canine Heritage Breed Test to its Innovative Assortment
Date:7/10/2008

TCOnews.com">PETCOnews.com.

About PETCO
PETCO is a privately held specialty retailer that provides products, services and advice that make it easier for our customers to be great pet parents. We operate more than 900 stores in 49 states and the District of Columbia, as well as a leading pet products and information destination at www.PETCO.com. Our nonprofit organization, The PETCO Foundation, has raised more than $44 million since its inception in 1999 to help promote and improve the welfare of companion animals. In conjunction with the foundation, we work with and support more than 5,000 local animal welfare groups across the country to help find homes for nearly 300,000 adoptable animals every year.

About MetaMorphix, Inc.
MetaMorphix, Inc. is a life sciences company that uses DNA to improve animal wellness. Its wholly owned subsidiary, MMI Genomics, has more than a decade of experience in the area of canine DNA research. As a world-leader in the discovery and commercialization of DNA-based marker systems that enhance the ability to identify individual dogs, verify parentage, determine breed type and confirm gender, MMI Genomics has been at the forefront of developing technology and providing value-added services to the canine community. This unparalleled leadership continues to help protect the efforts of canine registries and support dog owners and breeders around the world. For more information please visit us at www.Metamorphixinc.com.

Certain statements in this press release are forward-looking. These may be identified by the us
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related biology technology :

1. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
2. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance
3. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
4. Innovative Neurotronics, a Subsidiary of Hanger Orthopedic Group, Earns the 2007 da Vinci Award for the WalkAide System
5. CardioDynamics Receives FDA 510(k) Clearance for Innovative Clinical Parameters and Electronic Medical Record Compatibility
6. Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
7. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
8. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
9. Innovative Fosshield(R) Antimicrobial Technology Shown to Continuously Kill MRSA Superbug
10. Ferndale and Foamix Enter Development of an Innovative Foam for the Treatment of Atopic Dermatitis
11. A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PETCO Adds Canine Heritage Breed Test to its Innovative Assortment
PETCO Adds Canine Heritage Breed Test to its Innovative Assortment
(Date:11/24/2009).../--Sigma-AldrichCorporation(Nasdaq: SIAL )willbepr...1stat1:45PMGMTinLondon,7:45AMUS/CST.Interestedpart...ailableat http://inve s tor.sig m a a ldric...file. ,, AboutSigma-Aldrich: Sigma-Aldrichis...micalandbiochemicalproductsandkitsareusedinscienti...
(Date:11/24/2009)...DPharmaceuticalsInc.announced,theUSPatent&Trad...itsnano-particleoraldeliveryorNODtechnology. ,,...ratepeptidesor,proteinsintobio-adhesivenano-partic...edasinjections.NODtechnologyisaplatformtechnology,...ulin,interferon,growthhormone,exenatide,heparinan...
(Date:11/24/2009)...leEnergyCorp.announcedtodaythatthecompanyandtheOde...rded$2millionbyWashingtonState,sCommunityEconomicR...iptoconstructthestate,sfirstspecialtybiochemicalbi...willsignificantlyspeedthedevelopmentofourbiorefine...MarbleEnergyCEOKellyOgilvie."WearegratefultotheGov...
(Date:11/24/2009).../PRNewswire-FirstCall/-HamiltonThorneLtd.(TSX-V:HT...vancedlasersystemsandinstrumentsforthestemcellrese...onalandfinancialresultsforthethirdquarterendedSept...46millioncomparedwith$1.43millioninQ32008,-Grosspr...3,2008,-Netlossreducedto$148,000comparedto$283,000...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7
.... 28 Beckman,Coulter, Inc. (NYSE: BEC ), announc...ents with Adventist Health to provide a broad rang...t approximately $36 million over,six years. Advent... care,system with facilities in California, Hawaii...scom.com/cgi-bin/prnh/20031202/BECLOGO ), Under t...
...um Drives 71% Year-Over-Year Growth in Core ... Calif., Oct. 28 Cepheid (Nasdaq:,CPHD) today rep....9,million, an increase of 24% over the third quar...$(0.11) per share, which compares to revenue of $3....09) per share, in the third,quarter of fiscal 200...
...ovavax, Inc.,(Nasdaq: NVAX ) a clinical-stage vac...vi, President and Chief Executive Officer, will be... am. (PT) on October 30, 2008 at the,Palace Hotel ...vide an,overview of the company,s strategy, resear...esentation can be accessed via the Company website...
Other Biology Technology:Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care 2Cepheid Reports Third Quarter Revenue of $44.9 Million 2Cepheid Reports Third Quarter Revenue of $44.9 Million 3Cepheid Reports Third Quarter Revenue of $44.9 Million 4Cepheid Reports Third Quarter Revenue of $44.9 Million 5Cepheid Reports Third Quarter Revenue of $44.9 Million 6Cepheid Reports Third Quarter Revenue of $44.9 Million 7Cepheid Reports Third Quarter Revenue of $44.9 Million 8Cepheid Reports Third Quarter Revenue of $44.9 Million 9Cepheid Reports Third Quarter Revenue of $44.9 Million 10Cepheid Reports Third Quarter Revenue of $44.9 Million 11Cepheid Reports Third Quarter Revenue of $44.9 Million 12Cepheid Reports Third Quarter Revenue of $44.9 Million 13
(Date:11/24/2009)...of debate. A high-profile study a few years ago su...arbon from trees and leaves, evidence for a very c...ystems. , But new research from the University o...Algae provide a much richer diet for fish and othe...is week in the Proceedings of the National Academ...
(Date:11/23/2009)...vidence that the "synergistic" effect of early-lif...on and indoor endotoxin causes more harm to develo... , Environmental health scientists at the Univer...hown that children exposed to both high levels of ...ing early life are six times more likely to experi...
(Date:11/23/2009)...of day matters to forest trees dealing with drough... team led by Professor Malcolm Campbell, Universit...arch and colleagues in the department of cell and ...pitalizing on their previous work to decode the ge...d how poplar trees use their 45,000 genes to respo...
Breaking Biology News(10 mins):Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Time of day matters to thirsty trees, U of T researcher discovers 2Atlantic Pharmaceuticals Inc Announces Completion of Successful Pre IND Meeting with FDA for Abuse Deterrent Narcotic 49728 1Atlantic Pharmaceuticals Inc Announces Completion of Successful Pre IND Meeting with FDA for Abuse Deterrent Narcotic 49728 2Austrian IT Solutions Provider x tention IT GmbH Implements Entrust Versatile Authentication Platform 49723 1Austrian IT Solutions Provider x tention IT GmbH Implements Entrust Versatile Authentication Platform 49723 2Austrian IT Solutions Provider x tention IT GmbH Implements Entrust Versatile Authentication Platform 49723 3ThromCat 28R 29 XT 28TM 29 Thrombectomy Catheter System Receives CE Mark 49718 1ThromCat 28R 29 XT 28TM 29 Thrombectomy Catheter System Receives CE Mark 49718 2ThromCat 28R 29 XT 28TM 29 Thrombectomy Catheter System Receives CE Mark 49718 3
...ist has discovered key appetite control cells in t...ased hunger and potentially weight-gain as we grow...oendocrinologist with Monash University,s Departme..., Dr Andrews found that appetite-suppressing cell...aid the degeneration is more significant following...
... many men during their fight against prostate canc...searchers have found. The findings were published ...edings of the National Academy of Sciences . , Th...edeviled patients for decades. Hormone therapy, a ...ncer, generally keeps the cancer at bay for a year...
...s(TM) Wireless Data Communications Link School ..., WALL, N.J., Aug. 20 BIO-key International,Inc....sed biometric,identification and wireless public s...of MobileSRO(TM) and MobileCampus(TM), silent, sec...-12 schools and higher,education, respectively., ...
Other Biology News:Killer carbs -- Monash scientist finds the key to overeating as we age 2Why a common treatment for prostate cancer ultimately fails 2Why a common treatment for prostate cancer ultimately fails 3Why a common treatment for prostate cancer ultimately fails 4BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 2BIO-key(R) Announces Emergency Alert and Management Solutions for Schools and Campuses 3
Goat Anti-Human Serpin B5 / Maspin Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-SOX10 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-Human GMNN Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Normal Human Serum from 3H Biomedical AB
Biology Products: